DATE: October 16 6 AM Pacific Daylight Time and 4 PM Pacific Daylight Time
ABOUT THIS EVENT:

DNA and RNA sequencing technology and the burgeoning fields of proteomics and metabolomics are transforming our understanding of disease biology. Researchers are now rapidly discovering biomarkers to probe the underlying pathology of a disease and define the dynamic changes that occur during infection.

One researcher is at the cutting-edge of this field: Professor Michael Snyder at Stanford University is the first to relate personal genomics to 'omics' activity and interpret the medical relevance. And Professor Snyder should know best: he has been sequencing his genome and routinely drawing his own blood to track the changes in a billion biomarkers; including RNA, proteins, metabolites and antibodies to predict and validate disease risk.

In this webinar, Professor Snyder will discuss the profiling of personal transcriptomes, proteomes, cytokines, metabolomes and autoantibodies to create integrative Personal Omics Profiles (iPOP). Professor Snyder will explain how iPOPs can provide critical insight into the causes and development of disease.

In this webinar you will learn:

How 'omics' profiling of transcriptomes, proteomes, cytokines, metabolomes and autoantibodies has revealed dynamic and wide ranging variation in the different molecular components that occur during the progression of an infection
How analysis of heteroallelic expression suggests that significant changes in differential allele expression occur in healthy and disease states
How integrated analysis of multi-omic data on coding and gene regulation can lead to enhanced prediction of disease risk

SPEAKER:

Professor Michael Snyder, Geneticist, Stanford University

Michael Snyder received his PhD training at the California Institute of Technology and carried out his postdoctoral training at Stanford University. Since then, Michael Snyder has held several eminent research positions at both Yale and Stanford, and is currently the Stanford Ascherman Professor and Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine at Stanford University School of Medicine.

His laboratory was the first to perform a large-scale functional genomics project in any organism, and currently carries out a variety of projects in the areas of genomics and proteomics both in yeast and humans. These include not only a central role in the ENCODE project, but also the large-scale analysis of proteins using protein microarrays and the global mapping of the binding sites of chromosomal proteins. His laboratory built the first proteome chip for any organism and the first high resolution tiling array for the entire human genome.

свернуть